@longevitygeeklab: Dasatinib plus Quercetin: Longevity Research or Risk? One of the most studied senolytic combinations in humans combines: * dasatinib — a prescription leukemia drug * quercetin — a plant compound found in foods and supplements Researchers are studying this combination because it may help remove senescent “zombie cells” linked to aging-related decline. This video explains: * what D+Q is * why researchers are interested in it * what human trials currently show * why the data is still limited and mixed * why this is NOT a casual supplement stack Current evidence: * promising early human signals * ongoing clinical research * some conflicting aging-marker data * no proven anti-aging benefit in healthy humans yet Educational content only. Not medical advice. ⸻ KEYWORDS dasatinib, quercetin, d plus q, senolytics, senescent cells, zombie cells, longevity science, anti aging research, dasatinib quercetin, aging biology, healthy aging, cellular senescence, longevity supplements, biohacking, evidence based longevity, longevity geek, chemotherapy drug, anti aging therapy, senolytic research, aging markers

999

2026-05-18 19:46:04

To see more videos from user @longevitygeeklab, please go to the Tikwm homepage.